| Dr Ryan J Hadley, M D | |
|
4100 Lake Dr Se, Suite 200, Grand Rapids, MI 49546-8292 | |
| (616) 267-8244 | |
| Not Available |
| Full Name | Dr Ryan J Hadley |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 4100 Lake Dr Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770732414 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301096622 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Spectrum Health United Hospital | Greenville, MI | Hospital |
| Munson Healthcare Otsego Memorial Hospital | Gaylord, MI | Hospital |
| Spectrum Health Ludington Hospital | Ludington, MI | Hospital |
| Mclaren Northern Michigan | Petoskey, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Spectrum Health Primary Care Partners | 4587568647 | 1585 |
News Archive
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin.
The incoming C.I.A. director, David Petraeus, ought to impose clear restrictions and prohibitions on medically oriented spy tactics so that the integrity and humanitarian purpose of U.S. health aid are affirmed and that current and future health aid operations will not be misused," Jack Chow, a former U.S. global AIDS ambassador and assistant director-general of the WHO, writes in a New York Times opinion piece responding to reports that the U.S. used a vaccination campaign in Pakistan to help locate and kill Osama bin Laden.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
› Verified 1 days ago
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin.
The incoming C.I.A. director, David Petraeus, ought to impose clear restrictions and prohibitions on medically oriented spy tactics so that the integrity and humanitarian purpose of U.S. health aid are affirmed and that current and future health aid operations will not be misused," Jack Chow, a former U.S. global AIDS ambassador and assistant director-general of the WHO, writes in a New York Times opinion piece responding to reports that the U.S. used a vaccination campaign in Pakistan to help locate and kill Osama bin Laden.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan J Hadley, M D 100 Michigan St Ne, Mc 845, Grand Rapids, MI 49503-2560 Ph: () - | Dr Ryan J Hadley, M D 4100 Lake Dr Se, Suite 200, Grand Rapids, MI 49546-8292 Ph: (616) 267-8244 |
News Archive
"While two new members of House Appropriation Committee's State and Foreign Operations Subcommittee profiled in the Center for Global Health Policy's "Science Speaks" blog yesterday voted first for and then against the President's Emergency Plan For AIDS Relief, one of the three profiled in the blog on Thursday is an unambiguous supporter of global health initiatives, having played a pivotal role in virtually all legislation guiding America's HIV response for more than a decade," "Science Speaks" reports.
Accuray Incorporated and RaySearch Laboratories AB (publ) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch.
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Tradjenta (linagliptin) tablets for use as add-on therapy to insulin.
The incoming C.I.A. director, David Petraeus, ought to impose clear restrictions and prohibitions on medically oriented spy tactics so that the integrity and humanitarian purpose of U.S. health aid are affirmed and that current and future health aid operations will not be misused," Jack Chow, a former U.S. global AIDS ambassador and assistant director-general of the WHO, writes in a New York Times opinion piece responding to reports that the U.S. used a vaccination campaign in Pakistan to help locate and kill Osama bin Laden.
CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.
› Verified 1 days ago
Maureen U Tan- Pedres, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Suite A721, Grand Rapids, MI 49503 Phone: 616-391-3139 Fax: 616-391-3044 | |
Jeffery Allen Woo, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1900 Wealthy St Se, Ste 150, Grand Rapids, MI 49506 Phone: 616-459-3158 Fax: 616-988-0071 | |
Robert W Selfe, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 221 Michigan St Ne, Suite 200, Grand Rapids, MI 49503 Phone: 616-267-8950 Fax: 616-267-8585 | |
Dr. Erin Megan Pettijohn, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Cherry St Se Ste 2200, Grand Rapids, MI 49503 Phone: 616-685-5600 | |
Dr. Andrew Leo Sochacki, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5800 Foremost Dr Se Ste 200, Grand Rapids, MI 49546 Phone: 616-389-1800 | |
Stephanie F Williams, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 145 Michigan St Ne, Suite 5200, Grand Rapids, MI 49503 Phone: 616-486-5933 Fax: 616-486-6489 | |
Simin Beg, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 145 Michigan St Ne Ste 3410, Grand Rapids, MI 49503 Phone: 616-391-9945 |